![](/img/cover-not-exists.png)
Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines
Qian, Xiao-Long, Wen, Hannah Y., Yang, Yi-Ling, Gu, Feng, Guo, Xiao-Jing, Liu, Fang-Fang, Zhang, Lanjing, Zhang, Xin-Min, Fu, LiVolume:
159
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-016-3917-6
Date:
August, 2016
File:
PDF, 666 KB
english, 2016